The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Inflammatory mechanisms linking obesity and metabolic disease
Open accessAbstract
There are currently over 1.9 billion people who are obese or overweight, leading to a rise in related health complications, including insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration. The finding that obesity and metabolic disorder are accompanied by chronic low-grade inflammation has fundamentally changed our view of the underlying causes and progression of obesity and metabolic syndrome. We now know that an inflammatory program is activated early in adipose expansion and during chronic obesity, permanently skewing the immune system to a proinflammatory phenotype, and we are beginning to delineate the reciprocal influence of obesity and inflammation. Reviews in this series examine the activation of the innate and adaptive immune system in obesity; inflammation within diabetic islets, brain, liver, gut, and muscle; the role of inflammation in fibrosis and angiogenesis; the factors that contribute to the initiation of inflammation; and therapeutic approaches to modulate inflammation in the context of obesity and metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that self-reported insomnia appears to result in a shift towards Th2 immunity”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [484]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Self-citationMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Self-citation
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 1,002
Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments
O'Sullivan, J. N., Lysaght, J., Donohoe, C. L., & Reynolds, J. V. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0069-7 · Cited by 143
Rodrigues, M. E. D. S., Houser, M. C., Walker, D. I., Jones, D. P., Chang, J., Barnum, C. J., & Tansey, M. G. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0546-4 · Cited by 141
Püschel, G. P., Klauder, J., & Henkel, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154358 · Cited by 156
“Eventually, however, the excessive supply of dietary lipids results in disproportionate adipocyte hypertrophy as well as hyperplasia that is not accompanied by sufficient capillarization [14,58,59].”
BackgroundKuraji, R., Sekino, S., Kapila, Y. L., & Numabe, Y. (2021) · Periodontology 2000 · doi:10.1111/prd.12387 · Cited by 146
Distinct properties of adipose stem cell subpopulations determine fat depot-specific characteristics
Nahmgoong, H., Jeon, Y. G., Park, E. S., Choi, Y. H., Han, S. M., Park, J., Ji, Y., Sohn, J. H., Han, J. S., Kim, Y. Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.014 · Cited by 135
IL1R1 is required for celastrol’s leptin-sensitization and antiobesity effects
Feng, X., Guan, D., Auen, T., Choi, J. W., Hernández, M. A. S., Lee, J., Chun, H., Faruk, F., Kaplun, E., Herbert, Z. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0358-x · Cited by 133
β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity
Valentine, J. M., Ahmadian, M., Keinan, O., Abu-Odeh, M., Zhao, P., Zhou, X., Keller, M. P., Gao, H., Yu, R. T., Liddle, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci153357 · Cited by 152
“Elevated adipose tissue inflammation and increased cytokine levels are well documented in obesity and type 2 diabetes mellitus (T2DM) (30–33) and may contribute to both insulin and catecholamine resistance (30, 34, 35).”
BackgroundMethodSelf-citationZeng, X., Chen, B., Wang, L., Sun, Y., Jin, Z. H., Liu, X., Ouyang, L., & Liao, Y. J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.04.032 · Cited by 130
“Diabetes mellitus is a chronic inflammatory disease [53].”
BackgroundHarms, M., Li, Q., Lee, S., Zhang, C., Kull, B., Hallén, S., Thorell, A., Alexandersson, I., Hagberg, C. E., Peng, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.026 · Cited by 137
“Given the profound role that the immune system can play in insulin resistance (Brestoff and Artis, 2015; Lee et al., 2018; Odegaard and Chawla, 2013; Saltiel and Olefsky, 2017), these results have far reaching implications that can help the study of adipocyte interaction with the immune system, immune cell recruitment…”
BackgroundHuh, J. Y., Reilly, S. M., Abu-Odeh, M., Murphy, A. N., Mahata, S. K., Zhang, J., Cho, Y., Seo, J. B., Hung, C., Green, C. R., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.010 · Cited by 125
Self-citationInflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
Luo, Y., & Lin, H. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.391 · Cited by 132
Inflammation‐mediated metabolic regulation in adipose tissue
Xu, S., Lu, F., Gao, J., & Yuan, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13724 · Cited by 137
“173 Therefore, insulin resistance represents a major pathological response linking inflammation and metabolism in metabolic diseases.”
BackgroundDietary Regulation of Immunity
Lee, A. H., & Dixit, V. D. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.013 · Cited by 127
Luo, Z., Ji, Y., Gao, H., Reis, F. C. G., Bandyopadhyay, G. K., Jin, Z., Ly, C., Chang, Y., Zhang, D., Kumar, D., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.042 · Cited by 127
Obesity: A neuroimmunometabolic perspective
Larabee, C. M., Neely, O. C., & Domingos, A. I. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0283-6 · Cited by 123
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 119
“2), including diabetes, cardiovascular disease, and cancer [56, 57].”
BackgroundZhang, Y., Wang, F., Tang, J., Shen, L., He, J., & Chen, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02354-4 · Cited by 121
“In addition to lipid accumulation, hepatic inflammation, activation of pro-inflammatory cytokines and related transcription factors are key mechanisms that disrupt insulin signaling and contribute to IR [27].”
BackgroundImpaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases
Massier, L., Blüher, M., Kovacs, P. L., & Chakaroun, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.616506 · Cited by 130
“This is of particular interest, as metabolic diseases are usually attended by a chronic low grade inflammation (43), possibly initiating a detrimental positive feedback loop.”
BackgroundWang, T., Yan, H., Lu, Y., Li, X., Wang, X., Shan, Y., Yi, Y., Liu, B., Zhou, Y., & Lü, X. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02117-y · Cited by 120
The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis
Che, T., Cheng, Y. Z., Tian, D., Zhang, X., Liu, X., & Wu, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773646 · Cited by 128
“A consequence of MS as a chronic, low-grade inflammation is insulin resistance (48, 49).”
BackgroundThe roles of osteocytes in alveolar bone destruction in periodontitis
Huang, X., Xie, M., Xie, Y., Feng, M., Lu, X., Li, X., & Chen, L. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02664-7 · Cited by 122
“Some systemic diseases, such as DM and RA, can cause chronic systemic inflammation, contributing to the activation of immune cells and elevation of inflammatory substances [130, 131], which can exacerbate the disruption of bone homeostasis in periodontitis.”
BackgroundMetabolic Syndrome During Perinatal Period in Sows and the Link With Gut Microbiota and Metabolites
Cheng, C., Wei, H., Yu, H., Xu, C., Jiang, S., & Peng, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01989 · Cited by 115
“Reduced insulin sensitivity has been correlated with changes in the immune status in pregnancy, including elevated levels of circulating pro-inflammatory cytokines that are thought to drive obesity-associated metabolic inflammation (Saltiel and Olefsky, 2017).”
BackgroundCOVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Bigdelou, B., Sepand, M. R., Najafikhoshnoo, S., Negrete, J. A. T., Sharaf, M., Ho, J. Q., Sullivan, I., Chauhan, P. S., Etter, M. M., Shekarian, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890517 · Cited by 126
“Inflammation can be associated with an increase of insulin resistance, as it has been shown that inflammatory signals generated as a result of obesity work to activate serine kinases that, in turn, impact and block insulin action and function (48).”
BackgroundAdipose tissue in health and disease
Harvey, I. C., Boudreau, A., & Stephens, J. M. (2020) · Open Biology · doi:10.1098/rsob.200291 · Cited by 126
Alsaied, T., Aboulhosn, J., Cotts, T. B., Daniels, C. J., Etheridge, S. P., Feltes, T. F., Gurvitz, M. Z., Lewin, M., Oster, M. E., & Saidi, A. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017224 · Cited by 118
Wang, Y., Tang, B., Long, L., Luo, P., Xiang, W., Li, X., Wang, H., Jiang, Q., Tan, X., Luo, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20315-9 · Cited by 113
Hu, Z., Guan, Y., Hu, W., Xu, Z., & Ishfaq, M. (2022) · PubMed Central · doi:10.22038/ijbms.2022.60380.13381 · Cited by 121
Li, X., Cao, X., Zhang, J., Fu, J., Mohedaner, M., Danzengzhuoga, Sun, X., Yang, G., Yang, Z., Kuo, C., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18611 · Cited by 115
Li, C., Fang, Q., Liu, M., & Lin, J. (2020) · Theranostics · doi:10.7150/thno.42167 · Cited by 118
“non-alcoholic fatty liver disease (NAFLD), resulting in a significant decrease in life expectancy as well as the quality of life [5, 6].”
BackgroundHuman αβ and γδ T Cells in Skin Immunity and Disease
Cruz, M. S., Diamond, A., Russell, A., & Jameson, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01304 · Cited by 119
“Diabetic wounds become arrested in a chronic state of inflammation that is caused by pro-inflammatory cytokines, such as TNF-α, secreted by adipocytes and immune cells (161).”
BackgroundPrattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 114
Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials
Panknin, T., Howe, C. L., Hauer, M., Bucchireddigari, B., Rossi, A., & Funk, J. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054476 · Cited by 111
Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management
Zhang, Y., Whaley‐Connell, A. T., Sowers, J. R., & Ren, J. T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.004 · Cited by 109
Xu, L., Nagata, N., Chen, G., Nagashimada, M., Zhuge, F., Ni, Y., Sakai, Y., Kaneko, S., & Ota, T. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000783 · Cited by 109
Inflammatory Signaling and Brown Fat Activity
Omran, F., & Christian, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00156 · Cited by 111
Batista, T. M., Jayavelu, A. K., Albrechtsen, N. J. W., Iovino, S., Lebastchi, J., Pan, H., Dreyfuss, J. M., Krook, A., Zierath, J. R., Mann, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.007 · Cited by 112
“Multiple studies have shown that a variety of circulating factors, including increased levels of free fatty acids, ceramides, cytokines and other inflammatory mediators, as well as altered levels of branched chain amino acids and other metabolites may be increased in serum of T2D patients and contribute to the insulin…”
BackgroundNatural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
Noce, A., Lauro, M. D., Daniele, F. D., Zaitseva, A. P., Marrone, G., Borboni, P., & Daniele, N. D. (2021) · Nutrients · doi:10.3390/nu13020630 · Cited by 120
“Excessive caloric intake causes hypertrophy and hyperplasia of the adipocytes, as occurs in obese subjects, resulting in metabolic alterations and in the onset of a low-grade chronic inflammatory state [25].”
BackgroundRegulation of inflammation as an anti‐aging intervention
Neves, J., & Sousa‐Victor, P. (2019) · FEBS Journal · doi:10.1111/febs.15061 · Cited by 110
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 116
“Insulin resistance may be induced by diabetes, hypertriglyceridemia, obesity, and systemic chronic inflammation [117].”
BackgroundThe complex relationship between obesity and neurodegenerative diseases: an updated review
Neto, A., Fernandes, A. M. A., & Barateiro, A. P. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1294420 · Cited by 120
“…milieu with the release of pro-inflammatory factors, such as tumor necrosis factor-α (TNF-α ), interferon (IFN)- γ , interleukin (IL)-1 β , IL-18, IL-6, and C-reactive protein, leading to a moderate chronic inflammation within the adipose tissue (Lumeng et al., 2007; Reilly and Saltiel, 2017).”
Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis
Fernández‐Veledo, S., Ceperuelo‐Mallafré, V., & Vendrell, J. J. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.06.003 · Cited by 110
Khumalo, G. P., Wyk, B.-E. V., Feng, Y., & Cock, I. E. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114436 · Cited by 110
Epigenetic modifiers as new immunomodulatory therapies in solid tumours
Aspeslagh, S., Morel, D., Soria, J., & Postel-Vinay, S. C. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy050 · Cited by 105
Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans
Xie, J., Zu, Y., Alkhatib, A. L., Pham, T., Gill, F., Jang, A., Radosta, S., Chaaya, G., Myers, L., Zifodya, J. S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1714 · Cited by 104
“One possible explanation, as our study suggests, is that thesemetabolic comorbidities (combined asMetS) are characterized by a low-grade systemic inflammation (14).”
BackgroundIntercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Tirosh, A., Tuncman, G., Calay, E. S., RATHAUS, M., Ron, I., Tirosh, A., Yalçın, A., Lee, Y. G., Livne, R., Ron, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.009 · Cited by 106
Gao, W., Jin, L., Li, D., Zhang, Y., Zhao, W., Zhao, Y., Gao, J., Zhou, L., Chen, P., & Dong, G. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01814-2 · Cited by 107
“Excess adipose tissue, especially visceral fat in obese individuals, induces several pathophysiological processes associated with CRC, such as insulin resistance, chronic tissue inflammation, and oxidative stress [6].”
BackgroundZhang, S., Waterhouse, G. I. N., Xu, F., He, Z., Du, Y., Lian, Y., Wu, P., & Sun‐Waterhouse, D. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1988897 · Cited by 107
Chen, Z., Liu, N., Tang, H., Gao, X., Zhang, Y., Kan, H., Deng, F., Zhao, B., Zeng, X., Sun, Y., et al. (2022) · Indoor Air · doi:10.1111/ina.13170 · Cited by 103
Could ketogenic diet “starve” cancer? Emerging evidence
Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Renzo, L. D., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1847030 · Cited by 109
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Kuryłowicz, A., & Koźniewski, K. (2020) · Molecules · doi:10.3390/molecules25092224 · Cited by 104
“It was based on the initial observation that obese individuals, compared to these with normal body weight, are characterized by the permanently elevated serum levels of inflammatory markers such as C-reactive protein (CRP), tumor necrosis factor α (TNFα) or interleukin 6 (IL-6), consequently replicated by other author…”
BackgroundPasquarelli-do-Nascimento, G., Braz-de-Melo, H. A., Faria, S. S., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00530 · Cited by 103
Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K., & von Scholten, B. J. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2045952 · Cited by 115
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Goligher, E. C., Lawler, P. R., Jensen, T. P., Talisa, V. B., Berry, L. R., Lorenzi, E., McVerry, B. J., Chang, C. H., Leifer, E., Bradbury, C. A., et al. (2023) · JAMA · doi:10.1001/jama.2023.3651 · Cited by 103
Cai, X., Hu, J., Wen, W., Wang, J., Wang, M., Liu, S., Zhu, Q., Hong, J., Dang, Y., Yao, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4914791 · Cited by 101
Obesity and Aging in the Drosophila Model
Gáliková, M., & Klepsatel, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071896 · Cited by 97
“The immune response involves an increase in macrophage numbers, infiltration of the adipose tissue and other organs with macrophages, and enhanced production of proinflammatory cytokines TNF-α, interleukin 6 (IL-6), leptin, visfatin, resistin, and others [100,159].”
BackgroundInfluentialMetabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics
Ren, J. T., Sowers, J. R., & Zhang, Y. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.08.001 · Cited by 101
“Even a modest rise in body weight may place a considerable burden on type 2 diabetes risk and health care, through dyslipidemia including elevated levels of triglycerides, apolipoprotein B, low-density lipoprotein cholesterol (LDL-c), low HDL-c, low- grade inflammation, and endothelial injury [8, 11, 12].”
BackgroundSuppressing adipocyte inflammation promotes insulin resistance in mice
Zhu, Q., An, Y., Kim, M., Zhang, Z., Zhao, S., Zhu, Y., Asterholm, I. W., Kusminski, C. M., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101010 · Cited by 104
“Insulin resistance and adipose tissue inflammation correlate very well under many conditions, but a causal relationship between the two remains to be shown [3,4].”
BackgroundXu, L., Yan, X., Zhao, Y., Song, J., Liu, B., Yu, S., Fu, J., Liu, Y., & Su, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169252 · Cited by 109
Lin, Y., Bai, M., Wang, S., Chen, L., Li, Z., Li, C., Cao, P., & Chen, Y. (2022) · Diabetes · doi:10.2337/db21-0535 · Cited by 99
Metabolism-Associated Molecular Patterns (MAMPs)
Wang, X., Wang, Y., Antony, V., Sun, H., & Liang, G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.07.001 · Cited by 95
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Grabherr, F., Grander, C., Effenberger, M., Adolph, T. E., & Tilg, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00611 · Cited by 99
“Indeed, insulin resistance has long been assumed to be controlled by inflammatory pathways (83).”
BackgroundThe biology of human overfeeding: A systematic review
Bray, G. A., & Bouchard, C. (2020) · Obesity Reviews · doi:10.1111/obr.13040 · Cited by 97
Wang, S., Zhou, H., Zhao, C., & He, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.921085 · Cited by 109
“It is worth noting that obesityinduced inflammation involves multiple organs, including adipose, heart, skeletal muscle, pancreas, liver, and brain (12).”
BackgroundThe burden of metabolic syndrome on osteoarthritic joints
Dickson, B. M., Roelofs, A. J., Rochford, J. J., Wilson, H. M., & Bari, C. D. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-2081-x · Cited by 96
“MetS is accompanied by chronic low-grade systemic inflammation [5].”
BackgroundGenetics, epigenetics and transgenerational transmission of obesity in children
Panera, N., Mandato, C., Crudele, A., Bertrando, S., Vajro, P., & Alisi, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1006008 · Cited by 107
“In particular, over the past two decades, the mechanistic exploration of the nexus between obesity levels and metabolic diseases has highlighted a close relationship between nutrient excess, genetics, epigenetics, oxidative stress, and inflammatory signals (8, 9).”
BackgroundCao, Z., Zheng, X., Yang, H., Li, S., Xu, F., Yang, X., & Wang, Y. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-1012-6 · Cited by 98
Adipose tissue, systematic inflammation, and neurodegenerative diseases
Migliolo, L., Boleti, A. P. D. A., Cardoso, P. H. D. O., Frihling, B. E. F., Silva, P. S. E., & de Moraes, L. F. R. N. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343891 · Cited by 94
“In multiple sclerosis, proteases are released from microglia, proinflammatory cytokines, reactive oxygen species, and RNS, and they recruit reactive T lymphocytes, causing toxicity to neurons and oligodendrocyte precursors (Maldonado-Ruiz et al., 2017; Saltiel and Olefsky, 2017).”
Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity
Marruganti, C., Suvan, J. E., & D’Aiuto, F. (2023) · Periodontology 2000 · doi:10.1111/prd.12536 · Cited by 102
Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity
Shan, B., Shao, M., Zhang, Q., Hepler, C., Paschoal, V. A., Barnes, S. D., Vishvanath, L., An, Y., Jia, L., Malladi, V. S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00301-7 · Cited by 91
Anthocyanins in Chronic Diseases: The Power of Purple
Panchal, S. K., John, O. D., Mathai, M. L., & Brown, L. (2022) · Nutrients · doi:10.3390/nu14102161 · Cited by 94
Obesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
“These substances have the potential to intensify inflammatory states [192].”
Yan‐Do, R., & MacDonald, P. E. (2017) · Endocrinology · doi:10.1210/en.2017-00148 · Cited by 95
“resistance and impaired central metabolic sensing (85, 86).”
BackgroundGriffin, C. A., Eter, L., Lanzetta, N., Abrishami, S., Varghese, M., McKernan, K. E., Muir, L. A., Lane, J., Lumeng, C. N.-K., & Singer, K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001526 · Cited by 88
“Three decades of research have established the association among obesity, inflammation, and metabolic disease (1).”
BackgroundSearching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 90
β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity
Valentine, J. M., Ahmadian, M., Keinan, O., Abu-Odeh, M., Zhao, P., Zhou, X., Keller, M. P., Gao, H., Yu, R. T., Liddle, C., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 89
Self-citationGuria, S., Hoory, A., Das, S., Chattopadhyay, D., & Mukherjee, S. (2023) · Bioscience Reports · doi:10.1042/bsr20220200 · Cited by 105
Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction
Choi, W., Woo, G. H., Kwon, T., & Jeon, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199715 · Cited by 120
“TNF-α , one of the first adipose-derived factors implicated in obesity-linked insulin resistance, is overexpressed in obese fat and can trigger serine phosphorylation of insulin receptor substrates (IRS) via JNK activation, thereby blunting downstream insulin signaling [78,79].”
InfluentialTherapeutic Application of Exosomes in Inflammatory Diseases
Suh, J. H., Joo, H. S., Hong, E. B., Lee, H. J., & Lee, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031144 · Cited by 91
“For example, a correlation between obesity and inflammation has been studied in great deal, in accordance with the increasing frequency of obesity [18].”
BackgroundShabani, M., Sadeghi, A., Hosseini, H., Teimouri, M., Khorzoughi, R. B., Pasalar, P., & Meshkani, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-60185-1 · Cited by 91
Best practices in nutrition science to earn and keep the public's trust
Garza, C., Stover, P. J., Ohlhorst, S. D., Field, M. S., Steinbrook, R., Rowe, S. B., Woteki, C. E., & Campbell, E. G. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy337 · Cited by 92
“The persistent epidemic of obesity and overweight adds to the prevalence and severity of these conditions (25), and”
BackgroundKazierad, D. J., Chidsey, K., Somayaji, V. R., Bergman, A. J., Birnbaum, M. J., & Calle, R. A. (2021) · Med · doi:10.1016/j.medj.2021.04.007 · Cited by 85
Zheng, Y., Liu, W., Zhu, X., Xu, M., Lin, B., & Bai, Y. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103334 · Cited by 89
“There were studies reported that a high level of DII was associated with an increased risk of metabolic syndrome [25,26], because chronic inflammation is usually accompanied by metabolic disorders [27].”
BackgroundCasanova, E., Salvadó, M. J., Crescenti, A., & Gibert‐Ramos, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030532 · Cited by 86
“Moreover, targeting obesity-induced inflammation would be useful for the treatment of obesity and related diseases, since this state is linked to many illnesses or problematics, such as an overall activation of the immune system [46], cancer [47] or metabolic diseases [48].”
BackgroundDiet and Nutrients in Gastrointestinal Chronic Diseases
Corsello, A., Pugliese, D., Gasbarrini, A., & Armuzzi, A. (2020) · Nutrients · doi:10.3390/nu12092693 · Cited by 91
“In addition to this, the association between obesity, metabolic syndrome and inflammatory gut disorders has been widely demonstrated [67,68].”
BackgroundImpact of COVID-19 on the Cardiovascular System: A Review of Available Reports
Soumya, R. S., Unni, T. G., & Raghu, K. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07073-y · Cited by 92
Wan, Y., Xia, J., Xu, J., Chen, L., Yang, Y., Wu, J., Tang, F., Ao, H., & Peng, C. Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106002 · Cited by 87
Kwon, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900824 · Cited by 93
Nidadavolu, L. S., & Walston, J. D. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa209 · Cited by 86
“In particular, obesity and insulin resistance promote a proinflammatory state primed to release immunostimulatory factors (58).”
BackgroundMetabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
Denson, J. L., Gillet, A. S., Zu, Y., Brown, M., Pham, T., Yoshida, Y., Mauvais‐Jarvis, F., Douglas, I. S., Moore, M., Tea, K., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.40568 · Cited by 84
Zhu, Y., Wan, N., Shan, X., Deng, G., Xu, Q., Ye, H., & Sun, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.008 · Cited by 83
Lipid droplets and the host–pathogen dynamic: FATal attraction?
Bosch, M., Sweet, M. J., Parton, R. G., & Pol, A. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202104005 · Cited by 83
“For example, circulating fatty acids and oxidized lipids are damage-associated molecular patterns that have been widely implicated in PRR activation, thus connecting metabolic diseases with inflammatory phenotypes (Saltiel and Olefsky, 2017).”
BackgroundRomeo, S., Vidal‐Puig, A., Husain, M., Ahima, R. S., Arca, M., Bhatt, D. L., Diehl, A. M., Fontana, L., Foo, R., Frühbeck, G., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf314 · Cited by 93
“117 Activation of the canonical NOD, LRR, and pyrin domain–containing protein 3 (NLRP3) in inflammatory macrophages and adipocytes drives the production of pro-inflammatory cytokines such as tumour necrosis factor-α and interleukin (IL)-1, which in turn increases IL-6 production thereby promoting…”
NASH drug treatment development: challenges and lessons
Tilg, H., Byrne, C. D., & Targher, G. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00159-0 · Cited by 81
Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
Pessentheiner, A. R., Ducasa, G. M., & Gordts, P. L. S. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00769 · Cited by 83
Alam, I., Gul, R., Chong, J., Tan, C. T. Y., Chin, H. X., Wong, G. C. L., Doggui, R., & Larbi, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2007-z · Cited by 82
Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
Baggio, L. L., Varin, E. M., Koehler, J. A., Cao, X., Lokhnygina, Y. V., Stevens, S. R., Holman, R. R., & Drucker, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17556-z · Cited by 83
Obaid, M., Udden, S. M. N., Alluri, P. G., & Mandal, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-80291-4 · Cited by 83
Hird, E. J., Slanina-Davies, A., Lewis, G., Hamer, M., & Roiser, J. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02922-y · Cited by 79
Epigenetics of chronic inflammatory diseases
Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79
“T2DM is also characterized by life-threatening complications, which can reduce life expectancy, particularly cardiovascular disease.(50,51)”
BackgroundKomleva, Y. K., Chernykh, A., Lopatina, O. L., Gorina, Y. V., Lokteva, I., Salmina, A. B., & Gollasch, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.618395 · Cited by 83
Metadata
- Authors
- Saltiel, A. R., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-03
- Volume
- 127
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5199709
- OpenAlex
- W2567264284
- Cited by
- 2,212
- References
- 44
- Citations by year
- 2026: 261 · 2025: 318 · 2024: 265 · 2023: 255 · 2022: 308 · 2021: 280 · 2020: 270 · 2019: 136 · 2018: 80 · 2017: 36
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- University of California, San Diego (P30DK063491, DK063491)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, P30DK063491)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- obesity, metabolic syndrome, low-grade inflammation, insulin resistance, type 2 diabetes, adipose tissue expansion, innate immune system, adaptive immunity, neuroinflammation, liver inflammation, intestinal inflammation, skeletal muscle inflammation, fibrosis, angiogenesis, anti-inflammatory therapy
- MeSH terms
- Animals, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Inflammation, Neoplasms, Obesity, Organ Specificity, Neurodegenerative Diseases, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
